Wits Bara Clinical Trial Site
Johannesburg, Gauteng 2013
2 studies enrolling now · 13 studies all time
What they study most
Cardiovascular Disease, Cardiovascular Risk, Chronic Kidney Disease, Diabetes Mellitus, Type 2, Haemophilia A, Haemophilia A With Inhibitors, Heart Failure, Inflammation, Obesity, Overweight, Type 2 Diabetes
Studies at this site
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight — Recruiting now
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity — Recruiting now
- A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A — Recruiting now
- ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
- REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels — Running, not enrolling
- A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
- A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight — Completed
- A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP) — Completed
- A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes — Completed
- A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors — Completed
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec — Completed
- A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease — Completed
- Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed